Ukrainian veterinary manufacturer BIOTESTLAB has obtained marketing authorisations for 8 vaccines in Cambodia and is preparing to start exports to this new market.
The registered portfolio includes:
- 4 swine vaccines from the SUIMUN line;
- 3 poultry vaccines from the POLIMUN line;
- 1 cattle vaccine from the BOVIMUN line.
This milestone marks a new stage in BIOTESTLAB’s expansion across Southeast Asia, where the company is already present in Vietnam. Final logistical preparations are currently underway, and the first shipment is planned for spring 2026.
“Successful registration of our vaccines in Cambodia is part of BIOTESTLAB’s global development strategy, focused on fast-growing markets. We are ready to support regional partners with high-quality immunobiological and chemical-pharmaceutical solutions for animal and poultry health. We continue moving forward,” said Andrii Sobko, Director for Business Development and Business Process Improvement.
BIOTESTLAB continues to strengthen its international presence, with the company’s products already available in more than 20 countries worldwide.
Note
The full list of BIOTESTLAB products registered in Cambodia includes:
• vaccines against Classical swine fever (SUIMUN CSF LK-M), Aujeszky’s disease (SUIMUN ADIVAC, SUIMUN ADIVAC+), and Parvovirus and Erysipelas (SUIMUN PARVO ERY inac);
• vaccines against Gumboro disease (POLIMUN IBD), and Newcastle disease combined with Infectious bronchitis (POLIMUN La-Sota+H120, POLIMUN ND clone 124+IB H120);
• vaccine against Lumpy skin disease in cattle (BOVIMUN LSD).
Marketing authorisations are valid until 07 December 2030.